Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,601 signal articles · 135 in last 24h · 155,365 total before filter · latest 2h ago
135last 24h
852last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro192Earnings102M&A125Regulatory20Product22Analyst19
✕ clear all filtersticker: AMZNSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
From $100 billion to $27 billion: What happened to Shein?
Reuters Videos32d agoneutralVIDEO
From $100 billion to $27 billion: What happened to Shein?

<body><p>STORY: "Shein's valuation has dropped sharply in the past four years. It was valued at about $100 billion at its peak in 2022, but the valuation now is almost about a quarter of its peak valuation."</p><p>:: Hong Kong / August 24, 2026</p><p>:: Summer Zhen, Asia Funds Correspondent</p><p>"That is because the company is facing multiple challenges. The biggest one is the fierce competition from rivals such as Temu and Amazon."</p><p>"The company's sales growth is slowing down. It reported a first-quarter loss in first quarter. The company's app download is also declining quickly. That data has hurt investor confidence in the company."</p><p>"And in addition, both the U.S. and Europe, Shein's key markets, have imposed additional fees on small e-commerce parcels imported from China. That means consumers who buy Shein products now need to pay more.</p><p>"If a shopper now buys a €3 T-shirt on Shein, the cost could double after the fee."</p><p>"What's worse is that Shein's IPO comes at a challenging time. This year, all the investor focus is on AI and tech-related names such as Unitree IPO and CXMT, both blockbuster IPOs in China"</p><p>"The valuation of about $27 billion in its prospectus represents only about a quarter of that level and reflects investors' lukewarm interest."</p></body>

Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?
Insider Monkey33d agoneutral
Novo Nordisk Expands Its AI Push With AWS, But Can It Accelerate Drug Discovery?

Novo Nordisk A/S (NYSE:NVO) has entered a strategic partnership with Amazon Web Services to accelerate drug discovery and modernize its operations through artificial intelligence and cloud technology. The agreement establishes AWS as Novo Nordisk’s preferred cloud provider and strategic AI partner. The companies have also created a co-innovation hub in London, where AWS engineers and […]

AWS Was Lagging Microsoft Azure and Google Cloud in Growth—Is Amazon Finally Catching Up?
Insider Monkey33d agoneutral
AWS Was Lagging Microsoft Azure and Google Cloud in Growth—Is Amazon Finally Catching Up?

According to Rosenblatt’s Scott Devitt, Amazon (NASDAQ:AMZN)’s leading position in artificial intelligence remains underappreciated. This bold claim was made in a recent research note on August 19, where Devitt initiated coverage on the stock with a $335 price target. The firm anticipates AWS to exit 2026 at a 45% growth rate, compared with the Street’s […]